astrazeneca glp 1 drug A Guide to GLP-1s: Resources and support for GLP-1 medications Type 2 Diabetes: AstraZeneca's New

Corticosteroid injections: Effective for pain relief but associated with collagen fiber weakening and increased re-injury risk with repeated administration

doi:10.1016/S0969-2126(98)00074-4

Semaglutide is a GLP-1 receptor agonist (glucagon-like peptide-1) that has become one of the most studied compounds in metabolic and obesity research over the past decade

Considering the sensitive nature of reproductive health cases, reliance on current literature is needed to establish an unbiased literature summary

10.1016/j.bbih.2023.100646 63 GhanizadehA.AkhondzadehS.HormoziM.MakaremA.Abotorabi-ZarchiM.FiroozabadiA

Julie Pajaud was funded by the Conseil Rgional de Bretagne and the Ligue Contre le Cancer-Comit d'Ille-et-Vilaine